Blog
RSS FeedPosted by Michael Wonder on 10 Apr 2017
Woman's brain tumour shrunk by Keytruda
9 April 2017 - Not long ago Pamela Jones would have been told to get her affairs in order and ...
Posted by Michael Wonder on 10 Apr 2017
A look at whether your insurer will pay for what the Government won't if you get cancer
10 April 2017 - The C word – cancer – none of us want to hear it when we visit ...
Posted by Michael Wonder on 02 Apr 2017
300 cancer patients given a chance to live thanks to immunotherapy drugs
1 April 2017 - More than 300 people have been given another chance at life at a cost of more ...
Posted by Michael Wonder on 31 Mar 2017
Proposal to list 5-aminolevulinic acid hydrochloride (Gliolan) in the Hospital medicines list
31 March 2017 - PHARMAC is seeking feedback on a proposal to list 5-aminolevulinic acid hydrochloride (Gliolan) through a provisional ...
Posted by Michael Wonder on 28 Mar 2017
AIA NZ shakes up NZ’s insurance market with bolt-on cancer product
28 March 2017 - For the first time in New Zealand, families will be able to access the latest in ...
Posted by Michael Wonder on 22 Mar 2017
AIA launches insurance to pay huge costs of immunotherapy cancer drugs
22 March 2017 - Immunotherapy drugs can offer patients the chance of beating cancer, but the costs are high. ...
Posted by Michael Wonder on 13 Feb 2017
Outcomes from the November 2016 PTAC meeting
13 February 2017 - PHARMAC has published the minutes from the 3-4 November meeting. ...
Posted by Michael Wonder on 10 Feb 2017
Decision to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
10 February 2017 - PHARMAC is pleased to announce the approval of a proposal to maintain full subsidy for gefitinib ...
Posted by Michael Wonder on 09 Feb 2017
Terminal cancer patient priced out of life-prolonging medication
9 February 2017 - The husband of a terminal skin cancer patient says PHARMAC are "tightarses" and life saving medication ...
Posted by Michael Wonder on 02 Feb 2017
Mind the gap - an analysis of cancer medicines in New Zealand and Australia
2 February 2017 - When it comes making a difference in people’s lives, it’s not about how many medicines you ...
Posted by Michael Wonder on 02 Feb 2017
Quality over quantity more important in health outcomes
2 February 2017 - When it comes to making a difference in people’s lives, it’s not about how many medicines ...
Posted by Michael Wonder on 20 Dec 2016
Proposal to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
20 December 2016 - PHARMAC is seeking feedback on a proposal to amend the contractual terms of funding for gefitinib ...
Posted by Michael Wonder on 23 Oct 2016
Woman battling rare cancer gets PHARMAC funding for drug
24 October 2016 - A young woman with a body riddled with fast growing tumours, who was left in a ...
Posted by Michael Wonder on 20 Oct 2016
Woman in limbo over rare cancer treatment
21 October 2016 - For 23-year-old Olivia Fryer, three weeks could be everything. ...
Posted by Michael Wonder on 31 Aug 2016
Q&A: Is NZ lagging in cancer drug funding?
31 August 2016 - Researchers have called for an urgent overhaul of New Zealand's processes for funding cancer drugs to ensure ...